Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Comparison of HCV Prevalence in Pakistan and Iran; An Insight into Future
Author(s):
1Atta ur Rahman School of Applied Biosciences, National University of Science and Technology, Islamabad, Pakistan
Published online:Jan 12, 2014
Article type:Letter
Received:Apr 09, 2013
Accepted:Apr 28, 2013
How to Cite:Afzal MS, Ahmed T, Zaidi NUSS. Comparison of HCV Prevalence in Pakistan and Iran; An Insight into Future. Hepat Mon. 2014;14(1):e11466. doi: https://doi.org/10.5812/hepatmon.11466
Dear Editor,
A recent report by Shakeri et al. (March, 2013) published in Hepatitis Monthly showed that HCV prevalence is 0.2% in Mashad, Iran (1). Moreover, Previous report from Iran showed the similar prevalence of HCV in voluntaries blood donors (2). Pakistan, a neighboring country of Iran, is a low socioeconomic country having more than 10 million HCV infected people (3). Recently we have published the prevalence of HCV among 62,251 healthy blood donors from North West Province of Pakistan. The study showed that 2.6 % of healthy individuals were HCV antibody positive (4). We also concluded that the HCV prevalence is increasing with time when the results were compared with other previous reports.
HCV with more than 180 million infections worldwide (5), can lead to chronic infection and hepatocellular carcinoma (HCC) in 60% to 80% of infected individuals (6). Genetic differences among different ethnic groups results in differential susceptibility of infection and 20 % of infected individuals can clear the virus naturally due to their genetic makeup (7, 8). Better understanding of genetic factors, which are differentially distributed among different ethnic groups and have effect on hepatitis C susceptibility, progression, pathogeneses, would provide a scientific basis for HCV differential prevalence. Complete understanding the underlying molecular mechanisms involved in immune regulation in HCV infected patients will help in the development of new immunomodulatory treatments.
Currently there is no vaccine available to control HCV largely due to its unpredictable genomic variations. As Pakistani population is more affected with this deadly virus, a large proportion of infected individuals are in danger of developing cirrhosis and hepatocellular carcinoma. In Iran, the situation in not alarming currently but there is a need to conduct the continuous and regular prevalence studies on larger scale. As the incidence of HCV infection in Pakistan is increasing with time, the HCV prevalence studies are recommended in Iran on regular intervals to estimate the actual infection rate of HCV. Massive awareness campaigns are also needed to educate the general population about the roots of HCV spread and prevention methods to contain the deadly virus spread. It is observed that barbers and dentists are the major cause of viral spread in healthy population. Therefore, it is necessary to educate the barbers and dentists in Iran and their practices should be supervised more efficiently according to HCV safety protocols.
Acknowledgments
Footnotes
References
- 1.Shakeri MT, Nomani H, Ghayour Mobarhan M, Sima HR, Gerayli S, Shahbazi S, et al. The prevalence of hepatitis C virusin mashhad, iran: a population-based study. Hepat Mon. 2013;13(3). ee7723. [PubMed ID: 23745128]. https://doi.org/10.5812/hepatmon.7723.
- 2.Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol. 2002;17(10):1092-7. [PubMed ID: 12201870].
- 3.Anjum S, Ali S, Ahmad T, Afzal MS, Waheed Y, Shafi T, et al. Sequence and structural analysis of 3' untranslated region of hepatitis C virus, genotype 3a, from pakistani isolates. Hepat Mon. 2013;13(5). ee8390. [PubMed ID: 23922562]. https://doi.org/10.5812/hepatmon.8390.
- 4.Safi SZ, Afzal MS, Waheed Y, Butt UJ, Fatima K, Pervez Y, et al. Seroprevalence of hepatitis C and human immunodeficiency viruses in blood donors of northwestern Pakistan. Asian Biomed. 2011;5(3):389.
- 5.Waheed Y, Saeed U, Anjum S, Afzal MS, Ashraf M. Development of Global Consensus Sequence and Analysis of Highly Conserved Domains of the HCV NS5B Prote in. Hepat Mon. 2012;12(9). ee6142. [PubMed ID: 23087757]. https://doi.org/10.5812/hepatmon.6142.
- 6.Alavian SM. Triangular clinics: The way of the future. Hepat Mon. 2005;5(3):51-2.
- 7.Afzal MS, Tahir S, Salman A, Baig TA, Shafi T, Zaidi NU, et al. Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan. J Infect Dev Ctries. 2011;5(6):473-9. [PubMed ID: 21727647].
- 8.Afzal MS, Anjum S, Zaidi NU. Effect of Functional Interleukin-10 Polymorphism on Pegylated Interferon-alpha Plus Ribavirin Therapy Response in Chronic Hepatitis C Virus Patients Infected With 3a Genotype in Pakistani Population. Hepat Mon. 2013;13(6). ee10274. [PubMed ID: 24032042]. https://doi.org/10.5812/hepatmon.10274.
Copyright
Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Similar Articles
1
Oct
2009
15
Oct
2016
Healthcare and the Preventable Silent Killer: The Growing Epidemic of Hepatitis C in Pakistan
Kamiar Alaei,
Mohammad Sarwar,
Shao Chiu Juan,
Arash Alaei
24
Oct
2012
Epidemiological Pattern of Hepatitis B and Hepatitis C as Etiological Agents for Hepatocellular Carcinoma in Iran and Worldwide
Ahmed Zidan,
Hubert Scheuerlein,
Silke Schle,
Utz Settmacher,
Falk Rauchfuss
12
Mar
2013
The Prevalence of Hepatitis C Virus in Mashhad, Iran: A Population-Based Study
Mohammad Taghi Shakeri,
Hosein Nomani,
Majid Ghayour Mobarhan,
Hamid Reza Sima,
Sina Gerayli,
Shirin Shahbazi
,et al.6
Jan
2014
Changing of HCV Clade Pattern in Iran; the Possible Means for Something Good
Muhammad Sohail Afzal,
Sadia Anjum,
Najam us Sahar Sadaf Zaidi
Crossmark
Checking
Comments
Number of Comments:0Cited by
- Scopus by DOI: 15
Last Update: 1 month ago
- Scopus by Title: 15
Last Update: 1 month ago
- Scopus by Title (Ref): 15
Last Update: 1 month ago
- CrossRef: 9
Last Update: 9 hours ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCCÂ
Search Relations
Author(s):
Related Articles